Innovating Works

ONECHAIN IMMUNOTHERAPEUTICS SL

Activa
CARLY: Development and characterization of a novel CAR T-cell therapy for NHL FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Non-Hodgkin lymphomas (NHL) are a group of blood cancers characterized by the expansion of malignant B lymphocytes creating tumors throughou...
2024-03-26 - 2027-06-30 | Financiado
CARxALL: Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-... ONECHAIN IMMUNOTHERAPEUTICS SL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 R/R T-ALL remains a major clinical challenge. Despite improved survival rates thanks to intensive chemotherapy regimens, event-free (EFS) an...
2023-03-13 - 2026-03-31 | Financiado
ALERT: Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Acute Myeloid Leukemia (AML) results from the uncontrolled expansion of differentiation-defective hematopoietic stem/progenitor cells or imm...
2022-06-27 - 2026-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.